Long-Standing Distribution Agreement Between Instrumentation Laboratory and Beckman Coulter Comes to an End

(Brea, CA, USA) over their Hemostasis product line will terminate June 22, 2012.

Instrumentation Laboratory, a worldwide developer, manufacturer, and distributor of in vitro diagnostic instruments, related reagents, and controls, will end their distribution partnership with Beckman Coulter, a provider of instrument systems and products for life science. Beginning June 23, 2012, Instrumentation Laboratory will initiate direct sale and support services in the USA and Canada for their own Hemostasis product line in order to improve the quality of their products and services and simplify lab operations.

A strong focus on quality is precisely what has led to Instrumentation Laboratory’s success among hospitals and independent clinical laboratories worldwide, explained Ramon Benet, CEO, Instrumentation Laboratory, who is optimistic about the transition.

“[Instrumentation Laboratory] has achieved significant growth in Hemostasis, culminating in the attainment of the number one market share position worldwide, thanks to our focus on quality and innovation,” said Mr. Benet. “Now is the ideal time for us to apply our expertise, resources, and world-class service organization to working directly with our Hemostasis customers in North America, and focus on ensuring a smooth transition for our customers.”

Instrumentation Laboratories is currently the number one manufacturer of instruments and reagents for the Hemostasis market worldwide. Since the introduction of the first fully automated Hemostasis analyzer in 1985, the ACL 810, the company has continuously introduced innovative hospital and specialty lab products, culminating in the release of the ACL TOP Family of Hemostasis Testing Systems.

Along with Hemostasis systems, Instrumentation Laboratory’s product lines also include Critical Care and information management systems.



Related Links:

Instrumentation Laboratory

Beckman Coulter